| Detected | Trial | Change |
|---|---|---|
| 2026-06-10 | NCT06592924 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration… |
Trial sites expanded: 340 -> 368 locations |
| 2026-06-03 | NCT06931340 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy… |
Trial sites expanded: 186 -> 194 locations |
| 2026-05-16 | NCT04423211 Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted… |
Trial sites expanded: 303 -> 342 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-28 | NCT07611110 AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant… | Phase 3 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT04108208 | A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant… | Prostatic Neoplasms | Active, Not Recruiting |
| Phase 3 | |||
| NCT04134260 | Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation… | Prostate Adenocarcinoma | Recruiting |
| NCT04423211 | Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted… | Biochemically Recurrent Prostate Carcinoma | Recruiting |
| NCT06274047 | PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and… | Androgen Axis Suppression | Recruiting |
| NCT07611110 | AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant… | Metastatic Castration-resistant Prostate Cancer | Recruiting |
| NCT06931340 | Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy… | Castration-Sensitive Prostate Carcinoma | Recruiting |
| NCT06592924 | Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration… | Prostate Cancer (Adenocarcinoma) | Recruiting |
| NCT04513717 | Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment… | Prostate Adenocarcinoma | Active, Not Recruiting |
| NCT01946204 | A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate… | Prostatic Neoplasms | Active, Not Recruiting |
| NCT02257736 | An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With… | Prostatic Neoplasms | Active, Not Recruiting |
| NCT02489318 | A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT)… | Prostate Cancer | Active, Not Recruiting |
| NCT02531516 | An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer… | Prostatic Neoplasms | Active, Not Recruiting |
| NCT03767244 | A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced… | Prostatic Neoplasms | Active, Not Recruiting |
| NCT04557059 | A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With… | Prostatic Neoplasms | Active, Not Recruiting |
| NCT05884398 | A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With… | Metastatic Castrate-sensitive Prostate Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT05534646 | Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer | Castration-resistant Prostate Cancer | Recruiting |
| NCT05751941 | Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic… | Prostate Cancer | Recruiting |
| NCT06378866 | Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway… | Recurrent Castration-Sensitive Prostate Carcinoma | Recruiting |
| NCT04947254 | Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the… | Prostate Carcinoma | Recruiting |
| NCT02949284 | Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate… | Stage II Prostate Adenocarcinoma | Active, Not Recruiting |
| NCT03371719 | Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent… | Recurrent Prostate Carcinoma | Active, Not Recruiting |
| NCT04267887 | Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer | Castration-Sensitive Prostate Carcinoma | Active, Not Recruiting |
| NCT03902951 | Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate… | Metastatic Prostate Adenocarcinoma | Active, Not Recruiting |
| NCT02703623 | Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or… | Castration Levels of Testosterone | Active, Not Recruiting |
| NCT03412396 | Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy | Prostate Adenocarcinoma | Active, Not Recruiting |